Dr. Marta Wasiak, MD

NPI: 1346314291
Total Payments
$594.34
2024 Payments
$43.29
Companies
13
Transactions
34

Payment Breakdown by Category

Food & Beverage$594.34 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $594.34 34 100.0%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $176.25 15 $0 (2020)
Neuronetics, Inc. $62.51 1 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $60.77 4 $0 (2019)
Alkermes, Inc. $45.49 2 $0 (2024)
Allergan Inc. $43.77 2 $0 (2017)
Otsuka America Pharmaceutical, Inc. $42.01 2 $0 (2024)
Neos Therapeutics, LP $33.03 2 $0 (2019)
AbbVie Inc. $28.15 1 $0 (2023)
Teva Pharmaceuticals USA, Inc. $25.64 1 $0 (2023)
Lundbeck LLC $24.88 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $43.29 2 Alkermes, Inc. ($22.71)
2023 $98.00 4 AbbVie Inc. ($28.15)
2020 $81.83 6 Sunovion Pharmaceuticals Inc. ($81.83)
2019 $174.46 9 Neuronetics, Inc. ($62.51)
2018 $74.91 6 Takeda Pharmaceuticals U.S.A., Inc. ($35.70)
2017 $121.85 7 Allergan Inc. ($43.77)

All Payment Transactions

34 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
03/27/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $20.58 General
Category: PSYCHIATRY
01/30/2024 Alkermes, Inc. VIVITROL (Drug) Food and Beverage In-kind items and services $22.71 General
Category: CNS
11/17/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $28.15 General
Category: NEUROSCIENCE
09/25/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $21.43 General
Category: PSYCHIATRY
08/28/2023 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $25.64 General
Category: Neurology
07/26/2023 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $22.78 General
Category: CNS
08/27/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $16.80 General
Category: CNS
06/18/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $13.04 General
Category: CNS
05/21/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $14.09 General
Category: CNS
04/30/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $14.18 General
Category: CNS
02/06/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $12.50 General
Category: CNS
01/09/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $11.22 General
Category: CNS
08/27/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $1.73 General
Category: CNS
07/11/2019 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $24.88 General
Category: PSYCHIATRY
06/27/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $14.33 General
Category: Central Nervous System (CNS)
06/13/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $13.82 General
Category: CNS
06/13/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $10.74 General
Category: Central Nervous System (CNS)
04/18/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $12.14 General
Category: CNS
03/21/2019 Neuronetics, Inc. NEUROSTAR TMS THERAPY (Device) Food and Beverage In-kind items and services $62.51 General
Category: NEUROSTAR TMS THERAPY
03/07/2019 Neos Therapeutics, LP Adzenys XR-ODT (Drug), Cotempla XR-ODT Food and Beverage In-kind items and services $16.79 General
Category: ADHD
02/14/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $17.52 General
Category: CNS
12/13/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $18.33 General
Category: NEUROSCIENCE
08/22/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $3.00 General
Category: CNS
08/09/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $13.54 General
Category: CNS
08/06/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $18.04 General
Category: Central Nervous System (CNS)

About Dr. Marta Wasiak, MD

Dr. Marta Wasiak, MD is a Addiction Psychiatry healthcare provider based in Chico, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346314291.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marta Wasiak, MD has received a total of $594.34 in payments from pharmaceutical and medical device companies, with $43.29 received in 2024. These payments were reported across 34 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($594.34).

Practice Information

  • Specialty Addiction Psychiatry
  • Other Specialties Child & Adolescent Psychiatry, Psychiatry
  • Location Chico, CA
  • Active Since 11/20/2006
  • Last Updated 11/26/2024
  • Taxonomy Code 2084P0802X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1346314291

Products in Payments

  • LATUDA (Drug) $176.25
  • Trintellix (Drug) $76.37
  • VRAYLAR (Drug) $71.92
  • NEUROSTAR TMS THERAPY (Device) $62.51
  • Adzenys XR-ODT (Drug) $33.03
  • UZEDY (Drug) $25.64
  • REXULTI (Drug) $24.88
  • LYBALVI (Drug) $22.78
  • VIVITROL (Drug) $22.71
  • ABILIFY MAINTENA (Drug) $21.43
  • ABILIFY ASIMTUFII (Drug) $20.58
  • VYVANSE (Drug) $18.33
  • Dyanavel XR (Drug) $17.91

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.